Brief: Japan Tobacco, Torii sign agreement to market 2 new TAF-based anti-HIV drugs in Japan

Torii Pharmaceutical Co

02/03/2015 06:03

March 2 (Reuters) - Japan Tobacco Inc  2914.T  says: 
    * Signed agreement with Torii Pharmaceutical Co  4551.T  to 
market two new tenofovir alafenamide (TAF)-based anti-HIV drugs 
in Japan 
    * Says under terms of agreement, Torii holds exclusive 
rights to market the drugs in Japan subsequent to JT's obtaining 
manufacturing and marketing approval 
 
Source text for Eikon:  ID:nTSOB61e4f  
Further company coverage:  2914.T  
 
 (Tokyo Newsroom) 
 ((chris.gallagher@thomsonreuters.com;))